These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 968178)

  • 21. High-performance liquid chromatography assay of acebutolol and two of its metabolites in plasma and urine.
    Buskin JN; Upton RA; Jones RM; Williams RL
    J Chromatogr; 1982 Jul; 230(2):438-42. PubMed ID: 7107789
    [No Abstract]   [Full Text] [Related]  

  • 22. Quantitation of bisphenol A and bisphenol A glucuronide in biological samples by high performance liquid chromatography-tandem mass spectrometry.
    Völkel W; Bittner N; Dekant W
    Drug Metab Dispos; 2005 Nov; 33(11):1748-57. PubMed ID: 16103135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Observations on the pharmacokinetics of acebutolol.
    Kaye CM; Kumana CR; Leighton M; Hamer J; Turner P
    Clin Pharmacol Ther; 1976 Apr; 19(4):416-20. PubMed ID: 1269192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of cimetidine co-administration on the pharmacokinetics of acebutolol enantiomers and its metabolite diacetolol in a rat model: the effect of gastric pH on double-peak phenomena.
    Mostafavi SA; Foster RT
    Int J Pharm; 2003 Apr; 255(1-2):81-6. PubMed ID: 12672604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of effect of liver disease on the pharmacokinetics of acebutolol and diacetolol: a single dose study.
    Zaman R; Jack DB; Wilkins MR; Kendall MJ
    Biopharm Drug Dispos; 1985; 6(2):131-7. PubMed ID: 4005393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The biliary excretion of acebutolol in man.
    Kaye CM
    J Pharm Pharmacol; 1976 May; 28(5):449-50. PubMed ID: 6757
    [No Abstract]   [Full Text] [Related]  

  • 27. A strategy for a post-method-validation use of incurred biological samples for establishing the acceptability of a liquid chromatography/tandem mass-spectrometric method for quantitation of drugs in biological samples.
    Jemal M; Ouyang Z; Powell ML
    Rapid Commun Mass Spectrom; 2002; 16(16):1538-47. PubMed ID: 12203245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitation of the tetrachloroethylene metabolite N-acetyl-S-(trichlorovinyl)cysteine in rat urine via negative ion chemical ionization gas chromatography/tandem mass spectrometry.
    Bartels MJ
    Biol Mass Spectrom; 1994 Nov; 23(11):689-94. PubMed ID: 7811758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enantioselective high performance liquid chromatographic assay of acebutolol and its active metabolite diacetolol in human serum.
    Szymura-Oleksiak J; Walczak M; Bojarski J; Aboul-Enein HY
    Chirality; 1999; 11(4):267-71. PubMed ID: 10224653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of ketotifen and its conjugated metabolite in human plasma by liquid chromatography/tandem mass spectrometry: application to a pharmacokinetic study.
    Chen X; Zhong D; Liu D; Wang Y; Han Y; Gu J
    Rapid Commun Mass Spectrom; 2003; 17(22):2459-63. PubMed ID: 14608613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of atrazine and its metabolites in mouse urine and plasma by LC-MS analysis.
    Ross MK; Filipov NM
    Anal Biochem; 2006 Apr; 351(2):161-73. PubMed ID: 16527233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acébutolol: conditions of its interference in the estimation of urinary 17-oxosteroids. Method of estimation by Zimmerman's reaction (author's transl)].
    Thevenet M; Firmin C; Pouclet J
    Ann Biol Clin (Paris); 1979; 37(6):367-72. PubMed ID: 547762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of metabolism pathways of anticancer drugs by high-pressure liquid chromatography in combination with field desorption mass spectrometry.
    Przybylski M
    Arzneimittelforschung; 1982; 32(9):995-1012. PubMed ID: 6756419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A gas chromatographic mass spectrometric assay for plasma trifluoperazine concentrations following single doses.
    Midha KK; Roscoe RM; Hall K; Hawes EM; Cooper JK; McKay G; Shetty HU
    Biomed Mass Spectrom; 1982 May; 9(5):186-90. PubMed ID: 7093440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acebutolol pharmacokinetics in renal failure.
    Smith RS; Warren DJ; Renwick AG; George CF
    Br J Clin Pharmacol; 1983 Sep; 16(3):253-8. PubMed ID: 6626416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of enalapril and its active metabolite enalaprilat in plasma and urine by gas chromatography/mass spectrometry.
    Shioya H; Shimojo M; Kawahara Y
    Biomed Chromatogr; 1992; 6(2):59-62. PubMed ID: 1322206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. To nurse when receiving acebutolol: is it dangerous for the neonate?
    Boutroy MJ; Bianchetti G; Dubruc C; Vert P; Morselli PL
    Eur J Clin Pharmacol; 1986; 30(6):737-9. PubMed ID: 3770068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acebutolol and diacetolol plasma levels in patients undergoing myocardial revascularization with hypothermic cardiopulmonary bypass.
    Mantz J; Blanchot G; Marty J; Farinotti R; Trouvin JH; Hazebroucq J; Desmonts JM
    J Cardiothorac Anesth; 1990 Oct; 4(5):577-81. PubMed ID: 2132136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics in man of acebutolol and hydrochlorothiazide as single agents and in combination.
    Roux A; Le Liboux A; Delhotal B; Gaillot J; Flouvat B
    Eur J Clin Pharmacol; 1983; 24(6):801-6. PubMed ID: 6884417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of a gas chromatographic/mass spectrometric method for the determination of (E)-beta-fluoromethylene-m-tyrosine and its active metabolite in human plasma and urine.
    Schoun J; Duléry B; Haegele KD
    Biol Mass Spectrom; 1992 Dec; 21(12):625-32. PubMed ID: 1477108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.